News

Septerna eyes 2026 trial for new hypoparathyroidism treatment

Biotech company Septerna is currently conducting preclinical tests to identify a lead experimental therapy for hypoparathyroidism, with the hope of starting clinical trials in 2026. “We are executing effectively across our portfolio, with each program nearing important milestones,” Jeffrey Finer, MD, PhD, CEO and co-founder of Septerna, said…

Using real-time tech may help ID parathyroid glands during surgery

Technology used in real time may help surgeons identify a greater number of parathyroid glands during surgery — including in patients undergoing thyroidectomy, a procedure to remove part or all of the thyroid gland that is a common cause of hypoparathyroidism. That’s according to a new study that detailed…

Parathyroid gland transplant foils permanent hypoparathyroidism

Autotransplanting parathyroid glands to a muscle of the neck after surgery to remove the thyroid gland is tied to a higher risk of transient hypoparathyroidism, but progresses to permanent hypoparathyroidism less often, a study in China suggests. The risk of permanent hypoparathyroidism, that is, that which lasts more than…

Vertebral fracture risk higher in chronic hypoparathyroidism: Study

The risk of fractures in the vertebrae, the bones in the spine, was 55% higher in people with chronic hypoparathyroidism than in the general population, a nationwide study in Sweden found. Conversely, the risk of femur (thighbone) fractures was 30% less common in the hypoparathyroidism group. Chronic hypoparathyroidism patients…

Postoperative hypoparathyroidism linked to bladder issues

Women who develop hypoparathyroidism after surgery often have problems with bladder control, both on tests and in daily life, a small study found. The researchers recommended that checking urinary symptoms and bladder emptying be part of routine follow-up. The study, “Hypoparathyroidism is associated with bladder dysfunction, a preliminary…

Registrational trial of encaleret in chronic hypoparathyroidism sought

Treatment with the investigational therapy encaleret normalized calcium levels for most people with chronic hypoparathyroidism in a small proof-of-principle study. That’s according to data announced by Bridgebio Pharma, which is developing encaleret with its affiliate Calcilytix Therapeutics. The company said it hopes to launch a clinical trial…

Study highlights kidney function loss risk in hypoparathyroidism

People with long-lasting hypoparathyroidism after thyroid surgery are at risk of having deteriorating kidney function, according to a study from Spain. “This study demonstrated that patients were at greater risk of chronic kidney disease, progression to end-stage kidney disease, and faster decline in [kidney function] compared to subjects without…

Hypoparathyroidism in children often temporary after surgery

Hypoparathyroidism is often temporary in children who undergo surgical removal of the thyroid, or thyroidectomy, with most recovering normal parathyroid function within six months, a study in China shows. The time needed to recover from hypoparathyroidism was found to be closely related to the levels of parathyroid hormone (PTH)…